The world of biotech is both exhilarating and rewarding. However, picking the appropriate companies to invest in can be challenging and at times depressing. In this blog, you will find information gathered from industry reports, analyst forecasts, and market trends, helping you to emerge from mindless speculation and make intelligent investment decisions! - Michael Juan
Two companies up despite market losses - MannKind (MNKD) and pSivida (PSDV)
MNKD and PSDV were mentioned in my previous blog post as year-end biotech stocks with a chance to pop prior their PDUFA (prescription drug user fee act) actions date, Dec. 29, 2010 for both.
No comments:
Post a Comment